Kraig Biocraft Laboratories completes first phase of Dragon Silk fiber production for its military contract

ANN ARBOR, Mich., -December 19, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it completed the first batch of Dragon Silk™ cocoon production for its recently reported military contract.  The fibers will soon be headed to a reeling facility to be prepared for delivery to Warwick Mills.

The Company will contract Warwick Mills to produce ballistic shoot packs, for delivery to the US Army, based on the Company’s Dragon Silk technology.  The Company expected to make final delivery to the US Army in the second quarter of 2017.

“The Indiana factory scale up of our proprietary recombinant spider silk, we call Dragon silk, has exceeded our expectations.  As we ship this first batch of Dragon Silk cocoons dedicated for the US Army, we are already beginning to prepare for production of fibers ready for commercial sale to some of our primary end users,” said Company Founder and CEO Kim Thompson. 

The Company will now begin to sell its Dragon Silk and Monster Silk fibers, in earnest, to the various parties that have submitted sample requests, with priority given to substantive collaborative development agreements and key end uses.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to

For more information about Spider Silk, check it out at

About Warwick Mills

For the past century, Warwick Mills has been a leader in the engineering of technical textiles for protective applications. Warwick develops and integrates complex fiber composites for the most challenging safety applications. Its cooperative development strategy relies on its core technologies in technical textiles, custom adhesives, and performance coatings, from research and development to testing and full-scale manufacturing. This strategy ensures customer confidence for every challenge.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (, a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

This entry was posted on by .